HDITX

Heidelberg ImmunoTherapeutics GmbH is based in Heidelberg, Germany, and located in the new Bahnstadt area. We are a biopharmaceutical company focusing on the clinical development of innovative, antibody-based immunotherapeutics for the treatment of viral diseases and cancer... The company was founded as spin-off from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital in 2016. Our goal is to advance novel immunotherapeutics from preclinical research towards early Phase I and II clinical studies... Fighting the human herpes simplex virus and tumour diseases - Heidelberg ImmunoTherapeutics introduces immunotherapeutic agents into clinical use

Registration numbers: HRB 723806 (W)

Primary location: Heidelberg Germany